Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

ubiquitin-proteasome system

  • Open Access
    Ubiquitin-proteasome Pathway-linked Gene Signatures as Prognostic Indicators in Prostate Cancer
    YASUO TAKASHIMA, KENGO YOSHII, MASAMI TANAKA and KEI TASHIRO
    Anticancer Research May 2025, 45 (5) 1825-1841; DOI: https://doi.org/10.21873/anticanres.17562
  • You have access
    Ubiquitin-proteasome System Is a Promising Target for Killing Cisplatin-resistant Bladder Cancer Cells
    KAZUKI OKUBO, MAKOTO ISONO, TAKAKO ASANO, NINA REßING, WOLFGANG A. SCHULZ, FINN K. HANSEN and AKINORI SATO
    Anticancer Research June 2021, 41 (6) 2901-2912; DOI: https://doi.org/10.21873/anticanres.15072
  • You have access
    Acyclic Retinoid Combined With Tenascin-C-derived Peptide Reduces the Malignant Phenotype of Neuroblastoma Cells Through N-Myc Degradation
    KAZUKI OTSUKA, MANABU SASADA, YU HIRANO, YUSUKE NOHARA, TAKUYA IYODA, YOSHIKAZU HIGAMI, HIROAKI KODAMA and FUMIO FUKAI
    Anticancer Research July 2019, 39 (7) 3487-3492; DOI: https://doi.org/10.21873/anticanres.13494
  • You have access
    Bortezomib Causes ER Stress-related Death of Acute Promyelocytic Leukemia Cells Through Excessive Accumulation of PML–RARA
    MARIKO TAKENOKUCHI, KAZUHIDE MIYAMOTO, KATSUYASU SAIGO and TAIZO TANIGUCHI
    Anticancer Research June 2015, 35 (6) 3307-3316;
  • You have access
    Ubiquitination and the Ubiquitin – Proteasome System in the Pathogenesis and Treatment of Squamous Head and Neck Carcinoma
    IOANNIS A. VOUTSADAKIS
    Anticancer Research September 2013, 33 (9) 3527-3541;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire